Plus Therapeutics Analyst Ratings
Plus Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/14/2023 | 220% | HC Wainwright & Co. | → $8 | Reiterates | Buy → Buy |
| 06/30/2023 | 220% | HC Wainwright & Co. | $3.5 → $8 | Maintains | Buy |
| 05/03/2023 | 380% | Maxim Group | $30 → $12 | Maintains | Buy |
| 04/21/2023 | 40% | HC Wainwright & Co. | → $3.5 | Reiterates | → Buy |
| 02/27/2023 | 40% | HC Wainwright & Co. | → $3.5 | Reiterates | → Buy |
| 10/07/2022 | 100% | JonesTrading | → $5 | Initiates Coverage On | → Buy |
| 07/22/2022 | 40% | HC Wainwright & Co. | $7 → $3.5 | Maintains | Buy |
| 02/11/2021 | 180% | HC Wainwright & Co. | → $7 | Initiates Coverage On | → Buy |
| 01/25/2021 | 220% | Ladenburg Thalmann | → $8 | Initiates Coverage On | → Buy |
| 10/16/2020 | 140% | Maxim Group | → $6 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月14日 | 220% | HC Wainwright公司 | →$8 | 重申 | 購買→購買 |
| 2023/06/30 | 220% | HC Wainwright公司 | $3.5→$8 | 維護 | 買 |
| 05/03/2023 | 380% | Maxim集團 | $30→$12 | 維護 | 買 |
| 04/21/2023 | 40% | HC Wainwright公司 | →$3.5 | 重申 | →購買 |
| 02/27/2023 | 40% | HC Wainwright公司 | →$3.5 | 重申 | →購買 |
| 10/07/2022 | 100% | Jones Trading | →$5 | 開始承保 | →購買 |
| 07/22/2022 | 40% | HC Wainwright公司 | $7→$3.5 | 維護 | 買 |
| 02/11/2021 | 180% | HC Wainwright公司 | →$7 | 開始承保 | →購買 |
| 2021/01/25 | 220% | 拉登堡·塔爾曼 | →$8 | 開始承保 | →購買 |
| 10/16/2020 | 140% | Maxim集團 | →$6 | 開始承保 | →購買 |
What is the target price for Plus Therapeutics (PSTV)?
Plus Treeutics(PSTV)的目標價格是多少？
The latest price target for Plus Therapeutics (NASDAQ: PSTV) was reported by HC Wainwright & Co. on August 14, 2023. The analyst firm set a price target for $8.00 expecting PSTV to rise to within 12 months (a possible 220.00% upside). 6 analyst firms have reported ratings in the last year.
2023年8月14日，HC Wainwright&Co.報道了Plus治療公司(納斯達克：PSTV)的最新目標價。這家分析公司將目標價定為8美元，預計PSTV將在12個月內上漲(可能上漲220.00%)。6家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Plus Therapeutics (PSTV)?
Plus Treeutics(PSTV)的最新分析師評級是什麼？
The latest analyst rating for Plus Therapeutics (NASDAQ: PSTV) was provided by HC Wainwright & Co., and Plus Therapeutics reiterated their buy rating.
普洛斯治療公司(納斯達克代碼：PSTV)的最新分析師評級是由HC Wainwright&Co.提供的，普洛斯治療公司重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Plus Therapeutics (PSTV)?
Plus Treeutics(PSTV)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Plus Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Plus Therapeutics was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Plus Treeutics的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Plus治療公司的上一次評級是在2023年8月14日提交的，所以你應該預計下一次評級將在2024年8月14日左右提供。
Is the Analyst Rating Plus Therapeutics (PSTV) correct?
分析師評級加治療(PSTV)正確嗎？
While ratings are subjective and will change, the latest Plus Therapeutics (PSTV) rating was a reiterated with a price target of $0.00 to $8.00. The current price Plus Therapeutics (PSTV) is trading at is $2.50, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Plus治療(PSTV)評級被重申，目標價在0.00美元至8.00美元之間。目前Plus Treateutics(PSTV)的交易價格為2.50美元，在分析師的預測範圍內。